$UNH

Healthcare surged in June. Raymond James is adding these two dividend payers to list of top picks

Healthcare rose more than 6% in June as investors favored defensives over tech. Raymond James refreshed its healthcare top-picks list, adding UnitedHealth Group (UNH) and Janus Living (JAN). UNH is up 28% YTD; Q1 adjusted EPS $7.23 on $111.72B revenue; raised dividend to $2.32. JAN, an REIT, debuted in March IPO at $20 and closed at $28.99; dividend yield 1.96%.

Original reporting
Published Jul 2, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 2, 2026, 8:41 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Healthcare surged in June. Raymond James is adding these two dividend payers to list of top picks — source image
Decision brief

The 30-second read

$UNHBullishLow
01

Why it matters

The actionable element is the analyst-driven catalyst framing: UNH is tied to an upcoming earnings date and margin/cost moderation thesis; JAN is tied to improving occupancy/margins and acquisition sourcing in seniors housing.

02

Market read

This is a buy-list refresh during a defensive rotation; it may influence short-term positioning but lacks new company-specific disclosures beyond previously referenced results and a dividend hike.

03

What to watch

For UNH, the article cites moderating cost trends but provides no new datapoint beyond prior quarter results; for JAN, the piece doesn’t quantify acquisition pipeline or occupancy trajectory, leaving execution risk.

Relevance 4/10Novelty 4/10Timing: into the July 16 UNH earnings window; post-list refresh for JAN

Background

Healthcare outperformed in June (+6% per the article) as investors rotated away from software and mega-cap tech; Raymond James refreshed its top picks with dividend payers.

Company-level read

Ticker impact

$UNHBullishMedium confidence
Context

Raymond James added UnitedHealth to its top healthcare picks, citing near-term upside around the July 16 earnings report and improving margins.

Expected impact

Moderate upside bias into the July 16 earnings window; limited impact beyond sentiment unless earnings confirm margin/cost moderation.

Evidence & confidence

The article is an analyst note update (not a new earnings print), but it includes concrete guidance context (prior quarter beat, raised full-year EPS, dividend hike) and a dated upcoming earnings catalyst.

$JANBullishMedium confidence
Context

Raymond James recommended Janus Living as a top pick, pointing to improving seniors housing fundamentals and acquisition sourcing in a fragmented market.

Expected impact

Potential near-term support from buy-list momentum; upside likely capped unless fundamentals or acquisition pipeline accelerates.

Evidence & confidence

This is primarily a promotional/strategy update, but it contains specific fundamental drivers and notes the IPO timing and current dividend yield, which can matter for positioning.

Market effects

Reinforces a defensive rotation into healthcare and dividend payers after tech weakness; may support relative performance of managed care and seniors housing.

Primarily US equity flows; no explicit cross-region catalyst beyond sector rotation.

Limited—framed as US healthcare positioning and cost-trend/margin dynamics.

Counterpoint

Top-pick additions can lag fundamentals; if medical cost trends re-accelerate or occupancy recovery stalls, the thesis could unwind despite the endorsement.

Key entities

  • UnitedHealth Group

    Added to Raymond James’ top healthcare picks; thesis centers on July 16 earnings upside, moderating medical costs, improving insurance/Optum margins, and a recent dividend increase.

  • Janus Living

    Added as a top pick; thesis centers on improving seniors housing fundamentals (occupancy, limited new supply, demographics) and acquisition sourcing in a fragmented market.

  • Raymond James

    Investment bank refreshing its top healthcare picks list with two dividend-paying stocks.

Related articles

$UNHMedAI 8/10

The One Cost Line UnitedHealth Stock Has Not Caught Up To Yet

UnitedHealth (UNH) reports Medicare costs below estimates for 2026, but commercial health plan costs are higher than expected. Management attributes commercial cost increases to the federal arbitration process under the No Surprises Act. UNH expects commercial margin recovery to extend past 2027, delaying full margin expansion. The company raised its 2026 adjusted EPS guidance to $19.50-$20 and maintains a 13%-16% long-term growth rate.

$UNHMed

Unitedhealth Group Inc (UNH) Stock News & Articles

UnitedHealth Group (UNH) shares fell 3% following TPG's acquisition of Florida WellMed Clinics, ahead of guidance reaffirmation. The deal involves Optum clinics that previously impacted UnitedHealth's profits. The company is set to reaffirm its guidance soon, which could validate the deal or raise concerns among investors.

$UNHMedAI 8/10

Dear UnitedHealth Stock Fans, Mark Your Calendars for October 1

UnitedHealth (UNH) shares have risen 19% YTD and 34.7% in six months, with Q2 earnings beating expectations and guidance raised. The stock has pulled back 15% from July's peak, trading below $400. UNH's forward P/E is 21.7, and it offers a 2.32% dividend yield. Analysts have a 'Strong Buy' consensus with a mean price target of $480.81.

$UNHMed

Why Is UNH Stock Trading At A Premium With The Slowest Growth?

UnitedHealth (UNH) trades at a premium valuation compared to peers Cigna (CI) and CVS, with a higher operating margin but slower revenue growth. UNH's premium is driven by its Optum services, with a 2026 earnings guidance of $19.50-$20.00 per share. The company faces pressure in its commercial book and is expanding access to care.